Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $2.80 per share, beating the Zacks Consensus Estimate of$ 2.39 per share. This compares to earnings of $2.69 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 17.15%. A quarter ago, it was expected that this medical research equipment and services provider would post earnings of$ 2.05 per share when it actually produced earnings of $2.27, delivering a surprise ...